The purpose of this study is to determine the safety of topical FP1198 for the treatment of moderate to severe cyclic breast pain (cyclic mastalgia) and to examine the clinical activity of FP1198.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
20
High dose FP1198 applied once daily to both breasts for 6 treatment cycles.
Women's Health Care
San Diego, California, United States
Horizons Clinical Research
Denver, Colorado, United States
Kentucky Medical Research Center
Lexington, Kentucky, United States
Salt Lake Research
Salt Lake City, Utah, United States
Reduction in breast pain
Time frame: six months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.